Dobrzanski, Mark J.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21

Scott I. Abrams, Mark J. Dobrzanski, Donald T. Wells, Stephen F. Stanziale, Sam Zaremba, Laura Masuelle, Judith A. Kantor, Jeffrey Schlom

Journal:

European Journal of Immunology

Year:

1995

Language:

english

File:

PDF, 1.11 MB

english, 1995

2

Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate “Natural” and “Inducible” CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer

Mark J. Dobrzanski, Kathleen A. Rewers-Felkins, Khaliquzzaman A. Samad, Imelda S. Quinlin, Catherine A. Phillips, William Robinson, David J. Dobrzanski, Stephen E. Wright

Journal:

Cancer Immunology, Immunotherapy

Year:

2012

Language:

english

File:

PDF, 744 KB

english, 2012

3

Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer

Mark J. Dobrzanski, Joyce B. Reome, James C. Hylind, Kathleen A. Rewers-Felkins, Khaliquzzaman Abulsamad, Shawna L. Adams

Journal:

Clinical Immunology

Year:

2008

Language:

english

File:

PDF, 1.84 MB

english, 2008

4

Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival

Mark J. Dobrzanski, Kathleen A. Rewers-Felkins, Imelda S. Quinlin, Khaliquzzaman A. Samad, Catherine A. Phillips, William Robinson, David J. Dobrzanski, Stephen E. Wright

Journal:

Clinical Immunology

Year:

2009

Language:

english

File:

PDF, 1.71 MB

english, 2009

5

Immunopotentiating Role of IFN-γ in Early and Late Stages of Type 1 CD8 Effector Cell-Mediated Tumor Rejection

Mark J. Dobrzanski, Joyce B. Reome, Richard W. Dutton

Journal:

Clinical Immunology

Year:

2001

Language:

english

File:

PDF, 308 KB

english, 2001

6

Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer

Joyce B Reome, James C Hylind, Richard W Dutton, Mark J Dobrzanski

Journal:

Clinical Immunology

Year:

2004

Language:

english

File:

PDF, 474 KB

english, 2004

7

A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis

Kristine L Stump, Lily D Lu, Pawel Dobrzanski, Cynthia Serdikoff, Diane E Gingrich, Ben J Dugan, Thelma S Angeles, Mark S Albom, Mark A Ator, Bruce D Dorsey, Bruce A Ruggeri, Matthew M Seavey

Journal:

Arthritis Research & Therapy

Year:

2011

Language:

english

File:

PDF, 1.09 MB

english, 2011

8

Differential enhancement and distribution of antigen-specific cells in various lymph nodes in response to locally inoculated bacterial antigens

Mark J. Dobrzanski, Tsu-Ju (Thomas) Yang

Journal:

Veterinary Immunology and Immunopathology

Year:

1991

Language:

english

File:

PDF, 881 KB

english, 1991

9

Elevated CD4 Antigen Expression Among Activated T Cells in Lymph Nodes Draining Mammary Regions Chronically Exposed to Staphylococcus aureus Antigen

Dobrzanski, Mark J., Yang, Tsu Ju

Journal:

Year:

1992

Language:

english

File:

PDF, 864 KB

english, 1992

10

Ag-Specific Type 1 CD8 Effector Cells Enhance Methotrexate-Mediated Antitumor Responses by Modulating Endogenous CD49b-Expressing CD4 and CD8 T Effector Cell Subpopulations Producing IL-10

Dobrzanski, Mark J., Reome, Joyce B., Hylind, James C., Rewers-Felkins, Kathleen A., Abdulsamad, Khaliquzzaman, Adams, Shawna L.

Journal:

Immunological Investigations

Year:

2008

Language:

english

File:

PDF, 682 KB

english, 2008

11

Expanding Roles for CD4 T Cells and Their Subpopulations in Tumor Immunity and Therapy

Dobrzanski, Mark J.

Journal:

Frontiers in Oncology

Year:

2013

Language:

english

File:

PDF, 810 KB

english, 2013

12

SPIE Proceedings [SPIE Defense and Security - Orlando, FL (Monday 28 March 2005)] Digital Wireless Communications VII and Space Communication Technologies - A modular programmable digital UHF transponder

Harris, Mark, Dobrzanski, Joe, Rao, Raghuveer M., Dianat, Sohail A., Zoltowski, Michael D., Singh, Rabindra, Miller, Susan P.

Year:

2005

Language:

english

File:

PDF, 642 KB

english, 2005

13

Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer

Wright, Stephen E., Rewers-Felkins, Kathleen A., Quinlin, Imelda S., Phillips, Catherine A., Townsend, Mary, Philip, Ramila, Dobrzanski, Mark J., Lockwood-Cooke, Pamela R., Robinson, William

Journal:

Journal of Immunotherapy

Year:

2012

Language:

english

File:

PDF, 401 KB

english, 2012

14

SPIE Proceedings [SPIE Lasers and Applications in Science and Engineering - San Jose, CA (Saturday 22 January 2005)] High-Power Diode Laser Technology and Applications III - Thermal properties of high-power diode lasers investigated by microthermography

Kozlowska, Anna, Zediker, Mark S., Weik, Fritz, Tomm, Jens W., Malag, Andrzej, Latoszek, Mateusz, Wawrzyniak, Piotr, Teodorczyk, Marian, Dobrzanski, Lech, Zbroszczyk, Mariusz, Bugajski, Maciej

Year:

2005

Language:

english

File:

PDF, 329 KB

english, 2005

15

Immunization with a Syngeneic Tumor Infected with Recombinant Vaccinia Virus Expressing Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Induces Tumor Regression and Long-Lasting Systemic Immunity

McLaughlin, Joanne P., Abrams, Scott, Kantor, Judy, Dobrzanski, Mark J., Greenbaum, Jordan, Schlom, Jeffrey, Greiner, John W.

Journal:

Journal of Immunotherapy

Year:

1997

File:

PDF, 1001 KB

1997